eMed Population Health is a clinician-led, technology-driven digital health company built to manage the sustainable use of GLP-1 medications.
eMed operates at the intersection of clinical rigor, technology, and scale.
Our GLP-1 Management Program integrates screening, prescribing, direct medication sourcing, adherence monitoring, lifestyle management, and biomarker testing — all in one seamless mobile platform.
Team
Led and advised by pioneers in healthcare and technology.
Including
Linda Yaccarino
CEO, eMed
Tom Brady
Founding Chief Wellness Officer
Dr.Dyan Hes
Chief Medical Officer
Eric Larsen
Former EVP, UnitedHealth Group
David Moore
Former EVP, Novo Nordisk
eMed has built the category leader in population health.
The industry has taken notice.
COVID Proven Success & Scale
Launched first FDA authorized at-home COVID Test/BinaxNOW”
1.2k+ clients, 6M+ users, 25M tests
.avif){kind=logo}
Aon selects eMed as its GLP-1 care partner and makes a strategic investment.
Thrive Global
Partnership to deliver behavior-change and lifestyle support.
CVS Health
Partnering with the nation’s largest PBM to unlock scalable, cost-controlled GLP-1 access for employers.
eMed raises $200M at a $2B+ valuation to support scale across growing market demand.
Whether you're building a
better benefits package or a better you, eMed can help.
